The ACR recently issued the first formal international consensus guidance statement on diagnosing and managing VEXAS syndrome ...

BoneXpert and IB-lab-PANDA demonstrated accurate bone age evaluations against manual ratings among pediatric patients with GHD.

Interquartile range increase in the cumulative exposure to heatwaves were associated with 0.023- to 0.031-year increases in biological age.

Using longitudinal MRI radiomics, biochemical biomarkers, and clinical factors improves prediction of progression in knee OA.

Very abnormal laboratory results were often already known or suspected or thought to be unrelated to DMARD use in RA.

Cemdisiran is a subcutaneously-administered, small interfering RNA therapeutic that reduces the production of complement factor 5 in the liver.

The overall discontinuation rate of medical cannabis use was 57.9% at 1 year among patients with musculoskeletal pain.

Oral semaglutide was linked to reduced SU levels among patients with T2D, particularly among individuals with hyperuricemia and those who switched from a DPP-4 inhibitor.

In Alaska, AN/AI adults have a significantly higher incidence and prevalence of SjD compared with estimates found in other populations.

Michelle Drerup, PsyD, discusses patients' complex & challenging management of fibromyalgia and sleep disorders.

Relative risks for all-cause, cardiovascular, and respiratory mortality were larger for fire-related PM2.5 than total PM2.5.

Older age and prior b/tsDMARDs exposure were associated with more severe ultrasound-detected inflammatory and structural changes in patients with PsA.